Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medclair ABNGM:MCLR -2.24%67 Current Ratio is 4.85 as of Mar. 2026, which is 94% above its 10-year median of 2.50. GuruFocus rates NGM:MCLR with a GF Score™ of 67/100 and a GF Value™ of kr2.35 (Modestly Overvalued). Among 854 Medical Devices & Instruments companies, Medclair AB ranks better than 76.23% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Medclair AB's current ratio for the quarter that ended in Mar. 2026 was 4.85.
Medclair AB has a current ratio of 4.85. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Medclair AB's Current Ratio or its related term are showing as below:
NGM:MCLR'
s Current Ratio Range Over the Past 10 Years
Min: 1.33 Med: 2.5 Max: 7.9
Current: 4.85
During the past 11 years, Medclair AB's highest Current Ratio was 7.90. The lowest was 1.33. And the median was 2.50.
NGM:MCLR's Current Ratio is ranked better than 76.23% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 2.5
vs NGM:MCLR: 4.85
Medclair AB (NGM:MCLR) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Medclair AB Current Ratio Related Terms
Medclair AB Current Ratio Historical Data
* Premium members only.
The historical data trend for Medclair AB's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGM:MCLR vs ABT, SYK, MDT: Current Ratio Comparison
For the Medical Devices subindustry, Medclair AB's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medclair AB Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's Current Ratio distribution charts can be found below:
* The bar in red indicates where Medclair AB's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medclair AB (NGM:MCLR) has a Current Ratio of 4.85 as of Mar. 2026. This is 94% above median its historical median of 2.50. Over the past decade, Medclair AB's Current Ratio has ranged from 1.33 to 7.90. According to the industry distribution chart, Medclair AB ranks #203 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 23.8%.
Is Medclair AB's Current Ratio too high?
Medclair AB's current Current Ratio of 4.85 is 94% above median its 10-year median of 2.50. Over the past 10 years, this metric has ranged from a low of 1.33 to a high of 7.90. The Medical Devices & Instruments industry median Current Ratio is 2.50. Medclair AB's value of 4.85 is 94% above this industry median. Based on the distribution chart, Medclair AB ranks #203 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medclair AB has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medclair AB's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medclair AB ranks #203 out of 854 companies for Current Ratio. This places Medclair AB in the top 24% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.50. Medclair AB's value of 4.85 is 94% above this benchmark. Historically, Medclair AB's own Current Ratio has ranged from 1.33 to 7.90 over the past decade. While the company's 10-year median is 2.50 vs. the industry median of 2.50, Medclair AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.50, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medclair AB's current Current Ratio of 4.85 is 94% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medclair AB's current Current Ratio is 4.85, which is 94% above median its own 10-year median of 2.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medclair AB stock overvalued right now?
Based on GuruFocus' analysis, Medclair AB (NGM:MCLR) is currently considered Modestly Overvalued. The stock's GF Value™ is kr2.35, compared to a current price of kr3.05 — trading 29.8% above its estimated fair value. The current Current Ratio is 4.85, which is 94% above median its 10-year median of 2.50 and 94% above the Medical Devices & Instruments industry median of 2.50. Medclair AB's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Medclair AB (NGM:MCLR), the current Current Ratio is 4.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medclair AB (NGM:MCLR) Overvalued in 2026?
Based on GuruFocus' analysis, Medclair AB stock appears to be overvalued.
The current stock price of kr3.05 is trading 29.8% above its estimated GF Value™ of kr2.35.
GuruFocus considers Medclair AB to be Modestly Overvalued.
Key valuation signals for NGM:MCLR:
Current Ratio: 4.85 (94% above median its 10-year median of 2.50)
GF Value™: kr2.35 vs. price of kr3.05 (29.8% above fair value)
Industry Position: 94% above the Medical Devices & Instruments median (#203 of 854)
No single metric tells the full story. See the NGM:MCLR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.
67GF Score
Get the complete analysis for NGM:MCLR
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:MCLR has been successfully added to your 
